Serum Trace Elements Profile in Graves' Disease Patients with or Without Orbitopathy in Northeast China
Overview
Biotechnology
General Medicine
Authors
Affiliations
Objective: The purpose of the present study was to investigate serum trace elements in Graves' disease (GD) patients with or without orbitopathy in Northeast China.
Methods: Patients with newly diagnosed Graves' disease (HyGD) ( = 66), GD patients with euthyroid status or subclinical thyroidism after treatment (EUGD) ( = 55), GO patients with euthyroid status or subclinical thyroidism after treatment (GO) ( = 57), and normal controls (NC) ( = 66) were enrolled in this study. Serum trace elements were measured with ICP-MS.
Results: Serum selenium (Se) levels in EUGD group (median: 7.53 g/dL), HyGD group (median: 6.76 g/dL), and GO group (median: 7.40 g/dL) were significantly lower than those in NC group (median: 9.20 g/dL, all < 0.01). Serum copper (Cu) levels in GO group (median: 95.93 g/dL) were significantly lower than those in the NC group (median: 113.59 g/dL, = 0.015). After being adjusted for multivariables, thyroid-specific antibodies grade was associated with low Se levels. Hyperthyroidism and thyroid-specific antibodies grade were associated with high Cu levels. In addition, orbitopathy was associated with low Cu levels.
Conclusions: Thyroid autoimmunity was associated with low Se levels. Hyperthyroidism and thyroid autoimmunity may be associated with relatively high serum Cu levels. Alternatively, ophthalmopathy may be related to low serum Cu levels.
Rostami R, Beiranvand A, Nourooz-Zadeh S, Rostami M, Mohammadi A, Nourooz-Zadeh J Int J Endocrinol Metab. 2025; 22(2):e145599.
PMID: 40071251 PMC: 11892519. DOI: 10.5812/ijem-145599.
Brylinski L, Kostelecka K, Wolinski F, Komar O, Milosz A, Michalczyk J Nutrients. 2025; 17(3).
PMID: 39940256 PMC: 11819802. DOI: 10.3390/nu17030398.
Effect of trace elements and nutrients on 21 autoimmune diseases: a Mendelian randomization study.
Jia M, Yin H, Liang Y, Jiang F, Li H Front Immunol. 2025; 15:1462815.
PMID: 39902040 PMC: 11788298. DOI: 10.3389/fimmu.2024.1462815.
Effect of micronutrients on the risk of Graves' disease: a Mendelian randomization study.
Chen F, Qiu R, Lin Z, Chen J, Liu P, Huang Y Front Nutr. 2024; 11:1432420.
PMID: 39717395 PMC: 11663635. DOI: 10.3389/fnut.2024.1432420.
Sun M, Yan G, Sun S, Li X, Sun W, Wang Y Clin Interv Aging. 2024; 19:1141-1151.
PMID: 38948168 PMC: 11214795. DOI: 10.2147/CIA.S464615.